Transposagen Biopharmaceuticals, Inc. | Transposagen | Genetically modified rat models
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
  • Rss
  • About
    • Our People
    • Career Opportunities
    • Investment Opportunities
    • Client Portfolio
  • Custom Model Generation
  • Research Models
  • Gene Modification Tools
    • XTN™ TALENs
      • Vote for your favorite TALEN
      • FLASH XTN™ TALEN Heterodimers
    • piggyBac™ Transposons
    • Footprint-Free™ Gene Editing
  • Technology Platforms
    • Research Applications
    • Therapeutic Applications
    • BioProduction Applications
  • Knock Out Rat Consortium
  • Contact
    • Research Funding & Partnering
    • Newsroom
Home» Newsroom

Transposagen’s FLASH™ XTN™ TALEN Technology Featured in Genetic Engineering and Biotechnology News (GEN)

Accessible XTN™ TAL Effectors Now Commercially Available FLASH™ XTN™ TALE Nuclease technology, discussed in GEN shows incredible promise in producing “…high-precision and high-efficiency modifications in a target gene sequence to produce basic research tools and to enable dramatically improved gene therapy.” -Anton Simeonov (NIH) XTN™ TALE effectors empower you to edit, knockout or knock-in any sequence for genome editing, with applications in cells, [...]

Read More

Transposagen Announces Availability of the Obese (OB) Rat™ knockout for Leptin

The Lepob mouse strain has been used for decades to study obesity and diabetes, as well as for screening drugs. Transposagen’s Obese (OB) Rat™ now provides researchers with the advantage of the rat’s size and physiology on a leptin knockout background. The OB Rat™ carries a mutation (Q92X) which introduces a premature stop codon and [...]

Read More
© 2013 Transposagen | Website Designed and Developed by Studio 2108